Alterations of the Gut Microbiota in Multiple System Atrophy Patients

Linlin Wan1, Xin Zhou1, Chunrong Wang1

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Neuroscience
|November 5, 2019
PubMed

Insights

Gut microbiota is altered in Multiple System Atrophy (MSA) patients. This study identified specific bacterial changes, offering new insights into the gut-brain axis in this neurodegenerative disease.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • Multiple System Atrophy (MSA) is a fatal neurodegenerative disease with challenging pathogenesis.
  • The brain-gut-microbiota axis is increasingly recognized for its role in neurological disorders.
  • Research on gut microbiota alterations in MSA using metagenomic sequencing is limited.

Purpose of the Study:

  • To characterize gut microbial composition and function in Chinese MSA patients.
  • To identify specific microbial taxa and pathways associated with MSA.
  • To explore the role of the gut-brain axis in MSA pathophysiology.

Main Methods:

  • Metagenomic sequencing of fecal samples from 15 MSA patients and 15 healthy controls.
  • Analysis of microbial community composition and functional pathways using the KEGG database.

Main Results:

  • Significant differences in gut microbial communities between MSA patients and healthy controls.
  • Increased abundance of genera *Akkermansia* and species *Roseburia hominis*, *Akkermansia muciniphila*, *Alistipes onderdonkii*, *Streptococcus parasanguinis*, and *Staphylococcus xylosus* in MSA patients.
  • Decreased abundance of genera *Megamonas*, *Bifidobacterium*, *Blautia*, *Aggregatibacter* and species *Bacteroides coprocola*, *Megamonas funiformis*, *Bifidobacterium pseudocatenulatum*, *Clostridium nexile*, *Bacteroides plebeius*, and *Granulicatella adiacens* in MSA patients.
  • Aberrant functional pathways identified in the fecal microbiome of MSA patients.

Conclusions:

  • Evidence of gut microbiota dysbiosis in Chinese MSA cohorts.
  • Findings support the involvement of the gut-brain axis in MSA.
  • This study provides a foundation for developing new hypotheses on MSA pathophysiology.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
876
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.8K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
712
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
360
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
589
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
692